Placebo single
Sponsors
NP Therapeutics, PHARMENTERPRISES LLC
Conditions
Covid19Healthy Volunteers
Phase 1
Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers
CompletedNCT04679493
Start: 2020-12-17End: 2021-04-09Updated: 2021-09-22
Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascending Doses of XC243 After Single and Multiple Oral Administration in Healthy Volunteers.
CompletedNCT05628116
Start: 2022-09-28End: 2023-09-21Updated: 2023-11-18